Related Experiment Video
Updated: Oct 3, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and
Edwin Wappl1, Alexandra Koschak, Michael Poteser
1Institut für Biochemische Pharmakologie, Abteilung Pharmakologie und Toxikologie, Institut für Pharmazie, Universität Innsbruck, Peter-Mayrstrasse 1, A-6020 Innsbruck, Austria.
Abstract:
We have investigated the functional consequences of three P/Q-type Ca(2+) channel alpha1A (Ca(v)2.1alpha(1)) subunit mutations associated with different forms of ataxia (episodic ataxia type 2 (EA-2), R1279Stop, AY1593/1594D; progressive ataxia (PA), G293R). Mutations were introduced into human alpha1A cDNA and heterologously expressed in Xenopus oocytes or tsA-201 cells (with alpha(2)delta and beta1a) for electrophysiological and biochemical analysis. G293R reduced current density in both expression systems without changing single channel conductance. R1279Stop and AY1593/1594D protein were expressed in tsA-201 cells but failed to yield inward barium currents (I(Ba)). However, AY1593/1594D mediated I(Ba) when expressed in oocytes. G293R and AY1593/1594D shifted the current-voltage relationship to more positive potentials and enhanced inactivation during depolarizing pulses (3 s) and pulse trains (100 ms, 1 Hz). Mutation AY1593/1594D also slowed recovery from inactivation. Single channel recordings revealed a change in fast channel gating for G293R evident as a decrease in the mean open time. Our data support the hypothesis that a pronounced loss of P/Q-type Ca(2+) channel function underlies the pathophysiology of EA-2 and PA. In contrast to other EA-2 mutations, AY1593/1594D and G293R form at least partially functional channels.
Insights
Investigating P/Q-type Ca(2+) channel mutations reveals functional consequences for ataxia. Some mutations cause channel dysfunction, supporting loss-of-function as a cause of episodic ataxia type 2 and progressive ataxia.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Ataxia, including episodic ataxia type 2 (EA-2) and progressive ataxia (PA), is linked to mutations in the alpha1A (Ca(v)2.1alpha(1)) subunit of P/Q-type Ca(2+) channels.
- Understanding the functional impact of these mutations is crucial for elucidating ataxia pathophysiology.
Purpose of the Study:
- To investigate the functional consequences of specific P/Q-type Ca(2+) channel alpha1A subunit mutations (R1279Stop, AY1593/1594D associated with EA-2, and G293R associated with PA).
- To determine if these mutations lead to a loss of channel function underlying ataxia.
Main Methods:
- Human alpha1A cDNA with specific mutations were expressed in Xenopus oocytes and tsA-201 cells.
- Electrophysiological analyses (current density, single channel conductance, current-voltage relationships, inactivation, recovery from inactivation) and biochemical analysis were performed.
Main Results:
- The G293R mutation reduced current density without altering single channel conductance.
- R1279Stop and AY1593/1594D mutations resulted in non-functional channels in tsA-201 cells, but AY1593/1594D showed partial function in oocytes.
- G293R and AY1593/1594D shifted the current-voltage relationship, enhanced inactivation, and AY1593/1594D slowed recovery from inactivation. G293R altered fast channel gating.
Conclusions:
- The findings support the hypothesis that a significant loss of P/Q-type Ca(2+) channel function contributes to the pathophysiology of EA-2 and PA.
- Unlike some other EA-2 mutations, AY1593/1594D and G293R mutations result in at least partially functional channels.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

